The firm will adapt multiplex panels for prognosis of septic shock patients to its array-based portable diagnostic platform.
London Health Sciences Center researchers published a study validating the accuracy of the method as a potential screening test for symptomatic male patients.
Researchers from both teams plan to continue to refine their findings toward creating simple PCR or other nucleic acid amplification-based assays.
ISS astronauts will soon begin testing the Oxford Nanopore MinIon and two PCR platforms while researchers on Earth continue to evaluate microarrays for use in space.
The approach can increase CpG coverage about 18-fold by inferring from existing data to predict methylation of sites outside those covered on the arrays themselves.
Several new laboratories started to offer NIPT locally in 2015, and some providers have been shifting to less-expensive non-NGS platforms.
The researchers were able to differentiate among patients with lung cancer, COPD, and health controls using the biomarkers.
The results could inform diagnosis and treatment for PTSD and PTSD-associated and inflammation-associated disorders.
UK-based XRGenomics is using Affymetrix's GeneTitan platform to develop a gene expression signature as a stratification tool for dementia research.
Prices in Germany for noninvasive prenatal testing have plummeted over the last year, driven by competition and process improvements.
NPR says the explosion and fire earlier this week at a Russian lab that stores dangerous pathogens revives the question of whether such samples should be kept.
According to Wired, Nebula Genomics is providing a way for people to get their genomes sequenced anonymously.
A 25-year-old woman tells Cosmopolitan about learning her APOE status at a young age.
In Science journals this week: a functional genomic screen uncovers drug combination that increases KRAS inhibitor efficacy in aggressive lung cancer, and more.